# Akiram Therapeutics: Research, Uppsala, Sweden

> Akiram Therapeutics: Akiram Therapeutics is a Swedish biotechnology company based in Uppsala, founded in 2021. Based in Uppsala, Sweden. Founded 2021.

Source: https://millionrounds.com/startup/akiram-therapeutics (Millionrounds; every figure on the page links to its filing or article)

Sweden · [Research startup](https://millionrounds.com/companies)

# Akiram Therapeutics

Akiram Therapeutics is a Swedish biotechnology company based in Uppsala, founded in 2021.

Funding reported Last round: Undisclosed round

Research Uppsala, Sweden

Company summary

- **Founded:** 2021 5 years old
- **Team:** 6 1 to 10 people
- **Funding reported:** 67.9M as listed, currency not stated
- **Last round:** Undisclosed round Nov 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Akiram Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Akiram Therapeutics

Akiram Therapeutics is a Swedish biotechnology company based in Uppsala, founded in 2021.

The company specializes in developing targeted molecular radiotherapy, particularly radioimmunotherapy, for patients with aggressive cancers that currently lack effective treatments. Their mission is to make these therapies widely accessible and to create personalized cancer treatments with fewer side effects. The company's primary product is a radiopharmaceutical drug candidate named 177Lu-AKIR001, which has received approval to start a Phase 1 clinical trial. This therapy combines a proprietary antibody targeting the cancer marker CD44v6 with a radioactive component, delivering targeted radioactivity to cancer cells while sparing healthy tissues. Akiram focuses on treating metastatic solid tumor malignancies, including aggressive thyroid cancer, head and neck cancer, acute myeloid leukemia, lung cancer, and gynecological cancers. The company is progressing through its clinical trials, with the first cohort completed and no safety concerns reported.

## What company datasets say Akiram Therapeutics raised

Funding, as reported

Reported in all **67.9M** in the source's currency

Rounds **1**

Last round **Undisclosed round**

Last round size **8.2M**

Last round date **Nov 2022**

Investors listed **1**

## Founders and team

From Akiram Therapeutics's own website: 4 founders, 3 on the team.

**Marika Nestor** Chief Executive Officer, Co-Founder

**Anja Mortensen** Chief Technology Officer, Co-founder

**Fredrik Frejd** Chief Strategy Officer, Co-founder

**Regulatory Affairs Strategist** Founder of SDS Life Science and SDS MedteQ

- **Peter Frank** Head of CMC
- **Anna Törner** Board member
- **Peder Walberg** Board Member

Advisers *Jan Zedenius*

## The company, in detail

What they build

Known for

radioimmunotherapy health care oncology first-in-class therapy biotechnology research antibody phage display distribution manufacturing healthcare cancer therapy preclinical cancer research antibody-based therapy medical research radioisotope delivery targeted molecular radiotherapy radiopharmaceuticals

Built with from their website

Microsoft Email Providers Microsoft Exchange Microsoft 365 Microsoft Exchange Online Outlook Microsoft 365 Apps & Services

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 2834
- **Region:** Uppsala County
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/akiram-therapeutics)

## Research in Sweden

Startups like it

- [**Anocca** Södertälje · founded 2014](https://millionrounds.com/startup/anocca)
- [**SmartCella Holding AB** Botkyrka · founded 2014](https://millionrounds.com/startup/smartcella-holding-ab)
- [**Navinci** Uppsala · founded 2004](https://millionrounds.com/startup/navinci)
- [**AnaCardio** Gothenburg · founded 2017](https://millionrounds.com/startup/anacardio)
- [**Strike Pharma AB** Uppsala · founded 2020](https://millionrounds.com/startup/strike-pharma-ab)
- [**Umecrine Cognition AB** Gothenburg · founded 2000](https://millionrounds.com/startup/umecrine-cognition-ab)
- [**Ljusgårda AB** Tibro · founded 2017](https://millionrounds.com/startup/ljusg-rda-ab)
- [**Empros Pharma** Gothenburg · founded 2014](https://millionrounds.com/startup/empros-pharma)

## Is this your company?

Add your raise, your deck and your story, and put Akiram Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)